JP2007248395A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007248395A5 JP2007248395A5 JP2006075498A JP2006075498A JP2007248395A5 JP 2007248395 A5 JP2007248395 A5 JP 2007248395A5 JP 2006075498 A JP2006075498 A JP 2006075498A JP 2006075498 A JP2006075498 A JP 2006075498A JP 2007248395 A5 JP2007248395 A5 JP 2007248395A5
- Authority
- JP
- Japan
- Prior art keywords
- acute coronary
- coronary syndrome
- adamts13
- amount
- von willebrand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006075498A JP4820192B2 (ja) | 2006-03-17 | 2006-03-17 | 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006075498A JP4820192B2 (ja) | 2006-03-17 | 2006-03-17 | 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007248395A JP2007248395A (ja) | 2007-09-27 |
| JP2007248395A5 true JP2007248395A5 (enExample) | 2009-04-23 |
| JP4820192B2 JP4820192B2 (ja) | 2011-11-24 |
Family
ID=38592839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006075498A Expired - Lifetime JP4820192B2 (ja) | 2006-03-17 | 2006-03-17 | 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4820192B2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2375181T3 (es) | 2002-05-09 | 2012-02-27 | The Brigham And Women's Hospital, Inc. | 1l 1rl-1 como un marcador de enfermedades cardiovasculares. |
| PL2386860T4 (pl) | 2006-04-24 | 2015-09-30 | Critical Care Diagnostics Inc | Przewidywanie śmiertelności i wykrywanie poważnej choroby |
| DK2482078T3 (en) | 2006-05-01 | 2016-05-02 | Critical Care Diagnostics Inc | Cardiovascular disease diagnosis |
| WO2009001743A1 (ja) | 2007-06-22 | 2008-12-31 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | 新規adamts-13改変体 |
| PT3093663T (pt) | 2008-04-18 | 2018-10-19 | Critical Care Diagnostics Inc | Previsão do risco de eventos cardíacos adversos maiores |
| ES2685503T3 (es) | 2008-12-05 | 2018-10-09 | Baxalta GmbH | Métodos de medida de la división in vivo de Factor von Willebrand mediada por ADAMTS13 y utilización de los mismos |
| US8501420B2 (en) * | 2009-08-31 | 2013-08-06 | Abbott Laboratories | Biomarkers for prediction of major adverse cardiac events and uses thereof |
| IN2015DN01767A (enExample) | 2012-08-21 | 2015-05-29 | Critical Care Diagnostics Inc | |
| CN106066401B (zh) * | 2014-03-07 | 2018-11-23 | 重庆早柒天生物科技股份有限公司 | 生物标志物vwf和adamts13及其在肝硬化诊断试剂中的用途 |
| CN110139935A (zh) | 2016-10-11 | 2019-08-16 | 美国控股实验室公司 | 用于测定adamts13酶活性的方法和系统 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6251393B1 (en) * | 1998-10-23 | 2001-06-26 | The Brigham And Women's Hospital, Inc. | Conformation-specific anti-von Willebrand Factor antibodies |
| JP4666942B2 (ja) * | 2003-04-25 | 2011-04-06 | 学校法人慶應義塾 | フォンビルブラント因子切断酵素遺伝子解析による血栓性疾患関連の遺伝子変異検出方法 |
| US7780831B2 (en) * | 2003-07-07 | 2010-08-24 | The University Of North Carolina At Chapel Hill | Assays for detection of von willebrand factor (vWF) multimers and for degradation of vWF by agents such as ADAMTS13 and related methods |
| JP4398188B2 (ja) * | 2003-07-09 | 2010-01-13 | 積水メディカル株式会社 | 急性冠症候群およびその病態の検査方法 |
| CA2550939A1 (en) * | 2003-12-22 | 2005-07-07 | Mitsubishi Kagaku Iatron, Inc. | Method of detecting thrombosis by measuring von willebrand factor-cleaving protease |
-
2006
- 2006-03-17 JP JP2006075498A patent/JP4820192B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009501333A5 (enExample) | ||
| Saenger et al. | Multicenter analytical evaluation of a high-sensitivity troponin T assay | |
| Póvoa et al. | Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study | |
| Francisco et al. | Serum markers of vascular inflammation in dyslipemia | |
| Martinelli et al. | High levels of factor VIII and risk of extra-hepatic portal vein obstruction | |
| Pieri et al. | Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis | |
| PL2386860T3 (pl) | Przewidywanie śmiertelności i wykrywanie poważnej choroby | |
| JP2011526693A5 (enExample) | ||
| JP2005509161A5 (enExample) | ||
| JP2018529931A5 (enExample) | ||
| JP2008533471A5 (enExample) | ||
| DE602004030586D1 (de) | Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis | |
| JP2008537474A5 (enExample) | ||
| HRP20130127T1 (hr) | Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega | |
| Pierce et al. | C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older | |
| JP2023503379A5 (enExample) | ||
| RU2016137685A (ru) | Способ диагностики туберкулеза | |
| CA2667957A1 (en) | Methods and apparatuses for electrochemical determination of factor xa inhibitors in blood samples | |
| JP2004530114A5 (enExample) | ||
| JP2007033132A5 (enExample) | ||
| JP2020514689A5 (enExample) | ||
| EP1200837A1 (en) | A method for predicting the presence of haemostatic dysfunction in a patient sample | |
| Wassell et al. | Faecal calprotectin: a new marker for Crohn's disease? | |
| Mentesoglu et al. | The association between Behçet disease activity and elevated systemic immune-inflammation index: A retrospective observational study in a tertiary care hospital. | |
| Madhurantakam et al. | COVID severity test (CoST sensor)—An electrochemical immunosensing approach to stratify disease severity |